Compounds > bromodeoxyuridine
Page last updated: 2024-08-17

bromodeoxyuridine and HPV Infection

bromodeoxyuridine has been researched along with HPV Infection in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CS; D'Ambrosio, SM; Ding, H; Duan, W; Guo, D; Han, C; Wang, D1
Bashkin, JK; Edwards, TG; Fisher, C; Fok, K; Helmus, M; Koeller, KJ; Slomczynska, U1
de Villiers, EM; Gruber, AD; Kopp-Schneider, A; Michel, A; Zentgraf, H1
Chakraborty, RN; Chatterjee, R; Mitra, RB; Mukhopadhyay, D1
Benedict-Hamilton, HM; Broker, TR; Chien, WM; Chow, LT; Noya, F1

Other Studies

5 other study(ies) available for bromodeoxyuridine and HPV Infection

ArticleYear
Sensitivity to the non-COX inhibiting celecoxib derivative, OSU03012, is p21(WAF1/CIP1) dependent.
    International journal of cancer, 2008, Dec-15, Volume: 123, Issue:12

    Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Bromodeoxyuridine; Cell Line; Cyclin A; Cyclin-Dependent Kinase Inhibitor p21; Embryo, Mammalian; Fibroblasts; Flow Cytometry; G1 Phase; Gene Silencing; Humans; Immunoprecipitation; Mice; Mouth Mucosa; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus E7 Proteins; Papillomavirus Infections; Proto-Oncogene Proteins; Pyrazoles; Repressor Proteins; Sulfonamides; Tumor Virus Infections

2008
HPV episome levels are potently decreased by pyrrole-imidazole polyamides.
    Antiviral research, 2011, Volume: 91, Issue:2

    Topics: Antiviral Agents; Binding Sites; Bromodeoxyuridine; Cell Line, Tumor; Distamycins; DNA, Viral; Female; Human papillomavirus 16; Human papillomavirus 18; Human papillomavirus 31; Humans; Immunohistochemistry; Inhibitory Concentration 50; Microbial Sensitivity Tests; Nylons; Papillomavirus Infections; Plasmids; Pyrroles; Replication Origin; Uterine Cervical Neoplasms; Viral Load

2011
E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice.
    Journal of virology, 2006, Volume: 80, Issue:22

    Topics: Alphapapillomavirus; Animals; Betapapillomavirus; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Epidermis; Female; Histocytochemistry; Immunohistochemistry; Keratin-6; Male; Membrane Proteins; Mice; Mice, Transgenic; Oncogene Proteins, Viral; Papilloma; Papillomavirus Infections; Phosphoproteins; Protein Precursors; Skin; Skin Neoplasms; Trans-Activators; Tumor Suppressor Protein p53

2006
Evaluation of argyrophilic nucleolar organizer regions (AgNORs) in oral carcinomas in relation to human papillomavirus infection and cytokinetics.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1997, Volume: 26, Issue:7

    Topics: Adult; Aged; Bromodeoxyuridine; Cell Division; Female; Humans; In Situ Hybridization; Male; Middle Aged; Mouth Neoplasms; Nucleolus Organizer Region; Papillomaviridae; Papillomavirus Infections; Prognosis; Silver Staining; Tumor Virus Infections

1997
Alternative fates of keratinocytes transduced by human papillomavirus type 18 E7 during squamous differentiation.
    Journal of virology, 2002, Volume: 76, Issue:6

    Topics: Autoradiography; Bromodeoxyuridine; Cell Cycle Proteins; Cell Differentiation; Cells, Cultured; DNA; DNA-Binding Proteins; Humans; In Situ Hybridization, Fluorescence; Keratinocytes; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus Infections; Polyploidy; S Phase; Thymidine; Transduction, Genetic; Tritium; Tumor Virus Infections

2002